Publication | Closed Access

Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses

Metabolic SyndromeGastrointestinal Peptide HormoneMedicineDiabetesGlycobiologyPhysiologyTerminalia ArjunaExperimental DiabetesDiabetes MellitusPharmacologyCardioprotective EffectsOxidative StressHealth Sciences